ROSCAP: Reduction of Smoking in Cardiac Patients Study
This study has been completed.
Information provided by:
Minneapolis Veterans Affairs Medical Center
First received: March 10, 2006
Last updated: October 23, 2008
Last verified: April 2005
Background. The ROSCAP Study was a randomized controlled trial in heart disease patients to test the effect of a smoking reduction intervention on cigarettes per day (cpd) and biochemical and clinical indicators of tobacco exposure. .
Behavioral: smoking reduction intervention (including NRT)
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Outcome Measures:
Secondary Outcome Measures:
- Smoking cessation, biomarker measures
| Estimated Enrollment:
| Study Start Date:
| Estimated Study Completion Date:
|Ages Eligible for Study:
||18 Years to 80 Years
|Genders Eligible for Study:
|Accepts Healthy Volunteers:
- smoked at least 15 cigarettes per day and had one of 11 cardiovascular disorders: history of myocardial infarction, coronary artery bypass surgery, angioplasty, stent placement, thrombolytic therapy, angina, arrhythmia, a history of cardiac arrest, greater than 50% coronary artery stenosis by angiography, ischemia on exercise tolerance testing or congestive heart failure, required to confirm that they were unwilling or uninterested in setting a stop smoking date in the next 30 days.
- 1) unstable angina within the past 2 weeks, 2) unstable psychiatric or substance use disorders or 3) contraindications to nicotine replacement therapy (including pregnancy or intention to become pregnant)
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.
To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.
For general information, see Learn About Clinical Studies.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00301626
|Minneapolis VAMC (111-0)
|Minneapolis, Minnesota, United States, 55417 |
||Anne Joseph, MD, MPH
||Minneapolis VAMC & University of Minnesota
No publications provided
History of Changes
|Other Study ID Numbers:
|Study First Received:
||March 10, 2006
||October 23, 2008
||United States: Food and Drug Administration
Keywords provided by Minneapolis Veterans Affairs Medical Center:
Additional relevant MeSH terms:
ClinicalTrials.gov processed this record on September 18, 2014